Background Streptococcus pneumoniae coinfection with influenza results in synergistic
lethality, but there are limited data on pneumococcal coinfection with severe acute …

Background While secondary pneumococcal pneumonia occurs less commonly after
coronavirus disease 2019 (COVID-19) than after other viral infections, it remains unclear …

Background Our understanding of the cocirculation of infrequently targeted respiratory
pathogens and their contribution to symptoms during the coronavirus disease 2019 (COVID …

Background Although recent epidemiological data suggest that pneumococci may contribute
to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in …

Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2)-infected individuals are at an increased risk for coinfections; therefore, physicians …

Background In the context of the COVID-19 pandemic the risk of misdiagnosis of other
causes of respiratory infection is likely. In this work we aim to describe the clinical …

Case reports of patients infected with COVID-19 and influenza virus (“flurona”) have raised
questions around the prevalence and severity of coinfection. Using data from HHS Protect …

Compared with other countries, a more substantial decrease in the incidence of invasive
pneumococcal disease was observed in Hong Kong, which is most likely attributable to the …

Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

Importance An association between pneumococcal nasopharyngeal carriage and invasive
pneumococcal disease (IPD) has been previously established. However, it is unclear …